Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
Fig 4
Distribution of node and edge types in the custom and OpenBioLink KGs.
The properties of each of the two networks are detailed in S7 Table.